Expert Video - What happens in treatment failure in AML?

Dr. Jamile Shammo, an expert on acute myeloid leukemia (AML) at Rush University Medical Group in Chicago, explains the hematological processes that occur in AML treatment failure. She talks about the differences in relapse due to induction failure, versus relapse after being in a period of remission. She also discusses bone marrow biopsy and some of the signs and symptoms of treatment failure in AML.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.